In addition, tumor-associated NETs can also support metastatic cells to evade immune response by creating a physical shield from cytotoxic immune cells, such as cytotoxic CD8+ T and natural killer cells (NKs), thus preventing interactions between tumor and effector immune cells (165, 166) (Figure 3). The gene discussed is CD8A; the disease is neoplasm.